Navigation Links
Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value
Date:7/2/2009

lth care system. Eisai employs approximately 10,000 employees worldwide.

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical Research Inc., a clinical development group; Eisai Inc., a commercial operation with manufacturing and marketing/sales functions; and Eisai Machinery U.S.A., which markets and maintains pharmaceutical manufacturing machinery. For more information about Eisai, please visit www.eisai.com.


'/>"/>
SOURCE Eisai Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
2. New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
3. Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
4. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
5. Angiomax Will Retain Decision Resources Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI
6. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
7. NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
8. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
9. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
10. Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
11. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...DIEGO, Nov. 6 Ardea Bios...mpany focused on the development of small-molecule...d human immunodeficiency virus (HIV), today report...r the third quarter and nine months ended Septembe.../cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Since ou...
(Date:11/6/2009)...ARCH TRIANGLE PARK, N.C., Nov. 6 C...ng orally-available antiviral therapeutics to addr...n the development of the company,s lead antiviral ... (WHO) and the Global Health Security Initiative (... being developed for the treatment of smallpox, as...
(Date:11/6/2009)...NTA, Nov. 6 GeoVax Labs...he Company"), an Atlanta-based, biopharmaceutical ...sed by HIV-1 (Human Immunodeficiency Virus) and ot...uarter 2009 financial results and provided an oper...dent and Chief Executive Officer commented, "We ar...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 1Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 3Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 4Photos 3A Balance Nutrition and Taste Reduce Food Waste 21 53446 1Photos 3A Balance Nutrition and Taste Reduce Food Waste 21 53446 2Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor 4810 1Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor 4810 2Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor 4810 3Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor 4810 4
...tents, is the ,crush, or ,culotte, technique bette... for an,arterial narrowing at the branchpoint of t... it can be challenging to achieve full coverage of...side branch. A new study,will provide intervention...two techniques produces the best long-term results...
...Designed for Type-2 Diabetes Patients Who Are Over...i-Diabetic Treatments Device Applies Electrical... March 28 New York-Presbyterian Hospital/Weill,Co...national clinical,research study of an investigati...h type-2 diabetes who are overweight and do not re...
Other Medicine Technology:Stenting Techniques Vie in Branchpoint Lesions 2New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients 2
(Date:11/7/2009)...ot spray from Greensations fights pain and increas...affeine. ThermaFeet targets foot pain and soreness...s Black Walnut, Goldenseal, Vitamin C and Alpha Li...y, NY (PRWEB) November 7, 2009 -- A new foot spray...lation with the power of hot peppers and caffeine....
(Date:11/6/2009)...l loaded with pledge-breaking tax hikes ,, WASHI... Americans for Tax Reform: ,, By formally endors...arack Obama effectively announced that the central...g the campaign, Obama made a "firm pledge" not to ...ess than $250,000 per year: ,, "I can make a fir...
(Date:11/6/2009)...rtment of Veterans Affairs held a historic three-d...e beginning of a new mission for the agency - to e...n 1,300 VA clinicians and health care specialists,...roviding support for homeless and low-income veter...ers represented by the National Coalition for Home...
(Date:11/6/2009)...a, Inc. (NYSE: HSP ), a leading global specialty ...day announced that the company will present at the...on Wednesday, Dec. 2, 2009 in New York City. ,, Th...Eastern time on Wednesday, Dec. 2, 2009. It will ...ive audiocast accessible via the investor relation...
(Date:11/6/2009)...rnment programs, expert says , , FRIDAY, N...t more difficult than ever before for many America... options are available, according to an expert fro... to your pharmacist, advised Carriann Richey, dire...cy practice at Butler,s College of Pharmacy and He...
Breaking Medicine News(10 mins):Health News:Hot Peppers and Caffeine Relieve Painful Feet, Toe Fungus and Foot Odor 2Health News:ATR: Obama Lied, His Tax Pledge Died 2Health News:ATR: Obama Lied, His Tax Pledge Died 3Health News:VA Summit Frames Plan to End Veteran Homelessness 2Health News: Pay Less for Prescription Drugs 2
...ewswire-FirstCall/ - NUCRYST Pharmaceuticals,a dev...ight infection and,inflammation, today announced t... and Chief Financial Officer, effective May 8, 200...ng to,Thomas E. Gardner, Chairman and Chief Execut...
...pharmaceutical marketing might be swaying clinicia...-- Bipolar disorder may be overdiagnosed, say rese...ity. , They found that fewer than half of patients...for DSM-IV (SCID). , Recent reports suggest that u...
... Shire plc(LSE: SHP, Nasdaq: SHPGY), the global sp... at a major scientific meeting findings from analy...ive alpha-2A-agonist. This compound, is an invest...data demonstrated that INTUNIV showed significant ...
...go Stephenson, founder and CEO,of iGuard.org, and ...presented new insight about the cholesterol loweri...d and Drug Administration (FDA). Although,prescrib... none of the prescribing information provides a cl...
...redible Hulk custom chopper!, PITTSBURGH, May 7 ...rcia and Sonia Adcock at the Contra Costa Bodybuil...e Chabot College Performing,Arts Center in Hayward...ship,event will showcase contestants in bodybuildi...
...art Failure, DALLAS, May 7 The American Heart As...rt Failure, its second of the,planned six-publicat...lation: Journal of the American Heart Association....ion of cardiology at,Tufts-New England Medical Cen...
Other Medicine News:Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 2Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 3Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 4Health News:Bipolar Disorder Might Be Overdiagnosed 2Health News:Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms 2Health News:iGuard.org Presents New Data on Statins at FDA Workshop Demonstrating How Patient-Reported Information Can Enhance Drug Safety Knowledge 2Health News:Fitness and Figure Professionals Adela Garcia and Sonia Adcock to Represent GNC at Contra Costa Championship 2Health News:American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier 2Health News:American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier 3
AUTO SYRINGE AS50 Infusion Pump
6060 MULTI-THERAPY Infusion Pump
...ith selectable performance parameters for a divers...E pumps allow the same IV delivery sets to be used... wasteful teardowns and excess costs. From simple ...x dose calculations, COLLEAGUE pumps can be config...
...d Laboratory Medicine at the Cleveland Clinic, one...ademic medical center laboratories. With a staff o...ts and PhDs, our laboratories generate over 7 mill...iagnostic consultations annually. Our Reference La...
Medicine Products: